drugset / Trial / NCT07094542

Jaw Muscle Pain Post Wisdom Molar Surgery

NCT07094542

RandomizedParallel-groupTriple-blindTreatment

Summary

The proposed design is a triple-blind, placebo-controlled randomized prospective phase II trial to assess the feasibility of employing the Temporo-masseteric Nerve Block (TMNB) injection to decrease jaw muscle pain, overall pain, improve mouth opening and minimize pain medication consumption. 80 participants undergoing lower third molar removal under sedation will be enrolled. Those who develop significant jaw muscle pain on the following day will be randomized to receive either the TMNB injection or a placebo. Daily ecological momentary assessments (EMAs) will be collected reflecting elements of patient experience for all participants. On Day 8, participants return for an end-of-study evaluation and return their unused pain medications. Up to 40 participants who are randomized to receive TMNB/placebo will be recruited to participate in a qualitative interview regarding their experience.

Timeline

Start
2026-09
Primary completion
2029-11
Completion
2030-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.8 ml Other
Subject Lidocaine Other / unclassified 2 % Other
Comparator Acetaminophen Small molecule 325 mg Oral
Background Epinephrine Other / unclassified Other
Comparator Ibuprofen Small molecule 600 mg Oral